Corporate Debt Is Heading for Worst Month Since February's Rout
(Bloomberg) -- Investment-grade bonds are set for the worst month since February's rout.
U.S. high-grade debt is headed for a decline of 1.2 percent this month and the worst October in a decade, according to the Bloomberg Barclays Indexes. The bonds still outperformed their junk-rated peers, which are set for a slide of 1.8 percent, the biggest in nearly three years. It would be the first time investment-grade has outperformed high-yield in five months.
A laundry list of worries -- from higher interest rates to trade-war concerns -- struck financial markets this month, and bonds have been no exception.
“High-yield underperforming U.S. IG makes sense in that it's clearly about risk right now,” Tim Doubek, a portfolio manager at Columbia Threadneedle Investments, said in an interview.
Read more: Junk Bonds Spooked by Worst October Since 2008 as Yields Spike
For the year, junk bonds are still doing better. They've handed investors returns of 0.72 percent, compared with a 3.5 percent loss for the better-rated debt.
“It's been kind of a confounding thing for us,” Doubek said. “Part of the IG total return shortfall can be explained by rising Treasury rates.”
| Read more about the bond market: |
|
To contact the reporter on this story: Jeremy Hill in New York at jhill273@bloomberg.net
To contact the editors responsible for this story: Christopher DeReza at cdereza1@bloomberg.net, Randall Jensen, Brendan Walsh
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.